[1]
D. Nan, C. Abraira-Meriel, S. de la Roz-Fernandez, T. Maestre-Orozco, J. L. Hernandez, and M. Fernandez-Ayala, “Delayed Use of the Recombinant Human IL-1 Receptor Antagonist Anakinra in Five COVID-19 Patients with Pulmonary Fibrosis and Persistent Hypoxaemia: A Preliminary Report”, EJCRIM, vol. 8, no. 10, Oct. 2021.